Comparison between Sunrest Lifescience IPO and Swashthik Plascon IPO.
Sunrest Lifescience IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Swashthik Plascon IPO is a SME Bookbuilding proposed to list at BSE SME.
| Sunrest Lifescience IPO | Swashthik Plascon IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Mark Corporate Advisors Pvt.Ltd. | Shreni Shares Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sunrest Lifescience IPO is up to ₹10.30 Cr whereas the issue size of the Swashthik Plascon IPO is up to ₹38.71 Cr. The final issue price of Sunrest Lifescience IPO is ₹84.00 per share and of Swashthik Plascon IPO is ₹86.00 per share.
| Sunrest Lifescience IPO | Swashthik Plascon IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹86.00 per share | |
| Issue Price (Final) | ₹84.00 per share | ₹86.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 12,25,600 shares | 45,00,800 shares |
| Fresh Issue Size (Amount) | up to ₹10.30 Cr | up to ₹38.71 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 12,25,600 shares | 45,00,800 shares |
| Issue Size Total (Amount) | up to ₹10.30 Cr | up to ₹38.71 Cr |
Sunrest Lifescience IPO opens on Nov 07, 2023, while Swashthik Plascon IPO opens on Nov 24, 2023. The closing date of Sunrest Lifescience IPO and Swashthik Plascon IPO is Nov 09, 2023, and Nov 29, 2023, respectively.
| Sunrest Lifescience IPO | Swashthik Plascon IPO | |
|---|---|---|
| Anchor Bid Date | Nov 23, 2023 | |
| Issue Open | Nov 07, 2023 | Nov 24, 2023 |
| Issue Close | Nov 09, 2023 | Nov 29, 2023 |
| Basis Of Allotment (Tentative) | Nov 15, 2023 | Dec 04, 2023 |
| Initiation of Refunds (Tentative) | Nov 16, 2023 | Dec 05, 2023 |
| Credit of Share (Tentative) | Nov 17, 2023 | Dec 05, 2023 |
| Listing date (Tentative) | Nov 20, 2023 | Dec 05, 2023 |
| Anchor Lockin End date 1 | Jan 03, 2024 | |
| Anchor Lockin End date 2 | Mar 03, 2024 |
Sunrest Lifescience IPO P/E ratio is 12.33, as compared to Swashthik Plascon IPO P/E ratio of 17.23.
| Sunrest Lifescience IPO | Swashthik Plascon IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Sunrest Lifescience Limited Financial Information (Restated)Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| Swashthik Plascon Limited Financial Information (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 60.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.91 | 43.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.33 | 17.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹36.05 Cr. | ₹151.05 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 53% | 22.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 98% | 17.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.64 | 2.89 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.81 | ₹4.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 65.59% | 14.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sunrest Lifescience IPO Retail Individual Investors (RII) are offered 6,12,800 shares while in Swashthik Plascon IPO retail investors are offered 6,12,800 shares. Qualified Institutional Buyers (QIB) are offered in Sunrest Lifescience IPO and 9,00,800 shares in Swashthik Plascon IPO.
| Sunrest Lifescience IPO | Swashthik Plascon IPO | |
|---|---|---|
| Anchor Investor Reserveration | 13,48,800 shares | |
| Market Maker Reserveration | 65,600 shares | 2,38,400 shares |
| QIB | 9,00,800 shares | |
| NII | 6,12,800 shares | 6,75,200 shares |
| RII | 6,12,800 shares | 15,76,000 shares |
| Employee | ||
| Others | ||
| Total | 12,25,600 shares | 45,00,800 shares |
Sunrest Lifescience IPO subscribed 48.54x in total, whereas Swashthik Plascon IPO subscribed 15.43x.
| Sunrest Lifescience IPO | Swashthik Plascon IPO | |
|---|---|---|
| QIB (times) | 3.42x | |
| NII (times) | 29.17x | 35.76x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 65.74x | 13.58x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 48.54x | 15.43x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
